Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2008
10/16/2008CA2720989A1 Methods for treating cancer
10/16/2008CA2720987A1 Dosages and methods for the treatment of cancer
10/16/2008CA2720983A1 Method of treating melanoma
10/16/2008CA2720982A1 Method of treating brain cancer
10/16/2008CA2693256A1 Methods of use of gamma inhibitor compounds for the attenuation of pain
10/16/2008CA2688736A1 Novel compositions containing lysozyme and c-1/c-4 polysaccharides and use thereof in oral care, cosmetology and dermatology, contraception, urology and gynecology
10/16/2008CA2686513A1 Antiviral treatments
10/16/2008CA2684957A1 Antibacterial 1,4,5-substituted aminoglycoside analogs
10/16/2008CA2684747A1 Salts of isophosphoramide mustard and analogs thereof
10/16/2008CA2684061A1 Novel hiv-1 reverse transcriptase codon deletion and its use in the management and treatment of hiv infections
10/16/2008CA2683857A1 Substituted deuterium enriched thiophenes for the treatment of hypertension
10/16/2008CA2683697A1 Methods and compositions for treating sleep-related breathing disorders
10/16/2008CA2683682A1 Phthalazinone derivatives and their use as medicament to treat cancer
10/16/2008CA2683653A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
10/16/2008CA2683647A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
10/16/2008CA2683641A1 Methods of treating cancer using pyridopyrimidinone inhibitors of pi3k alpha
10/16/2008CA2683611A1 Novel stable pharmaceutical compositions of clopidogrel bisulfate and process of preparation thereof
10/16/2008CA2683598A1 1,3,8-trisubstituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as ligands of the orl-i receptor for the treatment of anxiety and depression
10/16/2008CA2683584A1 Hydroxymethyl ether hydroisoindoline tachykinin receptor antagonists
10/16/2008CA2683557A1 Inhibitors of histone deacetylase
10/16/2008CA2683453A1 Substituted 2,3,4,5-tetrahydro-1h-pyrido[4,3-.beta.]indoles, methods for the production and use thereof
10/16/2008CA2683434A1 Development of molecular imaging probes for carbonic anhydrase-ix using click chemistry
10/16/2008CA2683433A1 Nitro-imidazole hypoxia imaging agents
10/16/2008CA2683431A1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
10/16/2008CA2683415A1 An oral pharmaceutical composition
10/16/2008CA2683409A1 A pharmaceutical composition of tacrolimus
10/16/2008CA2683407A1 Pharmaceutical cyclosporin compositions
10/16/2008CA2683398A1 Fused ring heterocycle kinase modulators
10/16/2008CA2683093A1 New drospirenone/17.beta.-estradiol regimen, pharmaceutical combination product and kit for performing this regimen
10/16/2008CA2683046A1 Non-nucleoside reverse transcriptase inhibitors
10/16/2008CA2682981A1 Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors
10/16/2008CA2682925A1 Heteroaryl amide analogues
10/16/2008CA2682891A1 5-oxoisoxazoles as inhibitors of lipases and phospholipases
10/16/2008CA2682875A1 Imidazolidine carboxamide derivatives as lipase and phospholipase inhibitors
10/16/2008CA2682822A1 Novel crystalline bepotastine metal salt hydrate, method for preparing same, and pharmaceutical composition comprising same
10/16/2008CA2682686A1 Methods and systems for treating cell proliferation disorders
10/16/2008CA2682589A1 Composition for promoting the maintenance and function of muscle-specific progenitor cells
10/16/2008CA2682507A1 Oxygen-generating compositions for enhancing cell and tissue survival in vivo
10/16/2008CA2682497A1 Agents that reduce neuronal overexcitation
10/16/2008CA2682347A1 A medicament for treating schizophrenia comprising cilostazol
10/16/2008CA2682340A1 [2 , 6] naphthyridines useful as protein kinase inhibitors
10/16/2008CA2682339A1 2 , 6-naphthyridine derivatives as protein kinase modulators
10/16/2008CA2682287A1 1-(1-benzylpiperidin-4-yl)benzimidaz0le -5-carboxylic acid derivatives for the treatment of diabetes mellitus
10/16/2008CA2682234A1 Compositions and methods for the treatment of heart failure
10/16/2008CA2682207A1 Quinazolinone derivatives as aldh-2 inhibitors
10/16/2008CA2682162A1 Pyrid-2-yl fused heterocyclic compounds, and compositions and uses thereof
10/16/2008CA2681864A1 Crystalline forms i and ii of [3-(4-{2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1h-imidazol-4-yl}-phenoxy)-propyl]-diethyl-amine
10/16/2008CA2681861A1 Ornithine derivative
10/16/2008CA2681560A1 Pteridinone derivatives for use as stearoyl coa desaturase inhibitors
10/16/2008CA2681529A1 2, 6, 9-substituted purine derivatives having anti proliferative properties
10/16/2008CA2681451A1 Anti-tumor activity of temsirolimus in papillary renal cell cancer
10/16/2008CA2681449A1 Combinations of statins and anti-obesity agent
10/16/2008CA2681221A1 Isoquinolinone derivatives and their uses
10/16/2008CA2681163A1 Heterocycles as orexin antagonists
10/16/2008CA2681143A1 Solid pharmaceutical composition comprising a benzimidazole-7-carboxylate derivative and a ph control agent
10/16/2008CA2680838A1 Intraocular pressure-lowering agent comprising compound having histone deacetylase inhibitory effect as active ingredient
10/16/2008CA2680683A1 Wortmannin-rapalog conjugate and uses thereof
10/16/2008CA2680682A1 Quinolines and their therapeutic use
10/16/2008CA2679551A1 Stable aqueous g-csf formulations
10/16/2008CA2678415A1 Wortmannin-rapamycin conjugate and uses thereof
10/16/2008CA2678055A1 Rna interference tags
10/15/2008EP1980617A1 Improved expression of HIV polypeptides and production of virus-like particles
10/15/2008EP1980612A1 Paraben compounds
10/15/2008EP1980568A1 Ethinylated hetero dinucleotide phosphate analoga, method for their manufacture and application thereof
10/15/2008EP1980564A1 Antibiotics containing borinic acid complexes and methods of use
10/15/2008EP1980561A1 Substituted 1h-pyrazolo[3,4-b] pyridine derivatives active as kinase inhibitors
10/15/2008EP1980560A2 C-glycoside derivatives for the treatment of diabetes
10/15/2008EP1980559A1 Cardiovascular agents
10/15/2008EP1980271A1 Medicine for transnasal administration
10/15/2008EP1980263A1 Combinations of immunosuppressive agents for the treatment or prevention of graft rejections
10/15/2008EP1980258A1 Composition having effect of lowering blood pressure and/or inhibiting increase in blood pressure and food and drink containing the same
10/15/2008EP1980257A1 Compositions and uses of galectin antagonists
10/15/2008EP1980256A1 OIL-IN-WATER TYPE EMULSION LOTION CONTAINING 22-OXA-1 alpha ,25-DIHYDROXYVITAMIN D3 AND METHOD OF TREATING SKIN DISEASE BY USING THE SAME
10/15/2008EP1980255A1 Pharmaceutical compositions containing synthetic steroid derivatives such as tibolone, minerals such as calcium and the active metabolite of vitamin d (calcitrol) for the prevention and treatment of osteoporosis and menopause
10/15/2008EP1980254A1 Means and methods for counteracting protein aggregation
10/15/2008EP1980253A1 Use of meloxicam formulations in veterinary medicine
10/15/2008EP1980252A2 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
10/15/2008EP1980251A1 Pyrrolo[3,2,1-ij]quinoline-4-one derivatives for treating tuberculosis
10/15/2008EP1980250A1 Use of mimosine or a derivative thereof for treating the cutaneous effects of psoriasis and related skin disorders, and cosmetic or pharmaceutical composition containing same
10/15/2008EP1980249A2 Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser
10/15/2008EP1980248A1 Composition for treating cancer cells and synthetic method for the same
10/15/2008EP1980247A1 Growth hormone secretion regulator
10/15/2008EP1980246A1 Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
10/15/2008EP1980245A1 Bilayer lyophilized pharmaceutical compositions and methods of making and using same
10/15/2008EP1980243A1 Liposome preparation
10/15/2008EP1980242A1 Compositions comprising drospirenone moleculary dispersed
10/15/2008EP1980240A1 Lyophilized pharmaceutical compositions and methods of making and using same
10/15/2008EP1979487A2 Cobalamin compositions for the treatment of cancer
10/15/2008EP1979480A2 Inhibition of viral gene expression using small interfering rna
10/15/2008EP1979458A1 Cleaning composition
10/15/2008EP1979367A2 Quinolin-4-one derivatives as modulators of abc transporters
10/15/2008EP1979360A1 Compounds and compositions as ppar modulators
10/15/2008EP1979357A1 Solid forms of a pyrrolopyrimidine derivative and their use as anti-tumor agents
10/15/2008EP1979355A1 Spiro imidazole derivatives as ppar modulators
10/15/2008EP1979353A2 Fused heterobicyclic kinase inhibitors
10/15/2008EP1979352A2 Pyridopyrimidone derivatives, preparation thereof, therapeutic use thereof
10/15/2008EP1979351A1 6-phenyl-1h-imidazo[4, 5-c]pyridine-4-carbonitrile derivatives as cathepsin k and s inhibitors
10/15/2008EP1979350A1 Aryl-isoxazol-4-yl-imidazo[1,2-a]pyridine useful for the treatment of alzheimer's disease via gaba receptors
10/15/2008EP1979347A2 Polycyclic 1,2,3,4-tetrahydro-isoquinoline derivatives and compositions comprising them as ppar modulators
10/15/2008EP1979346A1 Thiazole derivatives and use thereof
1 ... 3042 3043 3044 3045 3046 3047 3048 3049 3050 3051 3052 3053 3054 3055 3056 3057 3058 3059 3060 3061 3062 ... 7860